BLK Hospital gets an edge in Liver Transplant

New Delhi: BLK super speciality hospital ropes in a renowned liver transplant specialist and can rightfully boast of having an edge. One of the most accomplished and proficient surgeons in Surgical Hepatology and Liver Transplantation in India, Dr.  Abhideep Chaudhary has joined BLK Super Specialty Hospital as Director & HOD, Liver Transplant & HPB Surgery. More than 1250 successful liver transplant and HPB surgery with a success rate of over 90 % speaks a volume about his expertise.

Dr. Chaudhary specializes in Liver Transplant, Pancreas and Biliary Diseases and Minimally Invasive Surgery (Laparoscopic and Robotic Surgery) and has more than 18 years of excellent surgical experience.

“We are happy to introduce Dr. Abhideep Chaudhary in our highly advanced and state of the art facility, BLK Institute for Digestive and Liver Diseases.  Dr. Chaudhary is bringing in a rich experience of 18 years in performing more than 1250 successful Liver transplant and HPB Surgeries with a success rate of more than 90%. With Dr. Chaudhary on board, our Institute for Digestive & Liver Diseases has added one more highly experienced specialist at the Institute and this strengthens our faculty,” said Dr. Sanjay Mehta, Head, Medical Services, BLK Super Specialty Hospital.

Prior to BLK Super Specialty Hospital, Dr. Chaudhary has worked as an integral part of core specialists teams at several prestigious medical institutions in Delhi and NCR.  He also served as a Chief Clinical Fellow/Senior Administrative Fellow (Transplant Surgery) and Multiorgan Transplant Surgery Fellow at the University of Pittsburgh Medical Center, USA.

“Dr.  Abhideep has given a new dimension to the ways Specialists perform hyper reduced liver graft for small babies, posterior sector liver graft, dual lobe transplant, LDLT in patients with extensive portal vein Thrombosis. He is also known for performing simultaneous liver and kidney transplant. His expertise and experience would add further value to the Institute in terms of high-end transplants and treatment.” Added Dr. Mehta

“I would like to thank BLK Hospital for providing me the opportunity to work with excellent team here.  BLK Super Speciality Hospital is known for passion for healing and I have embraced its vision and mission to serve the patient with best-in class facilities and expertise, “said Dr. Chaudhary.

He is also an active member of various prominent medical organisations which include the American Society of Transplant Surgeons, Indian Medical Association, Association of Surgeons of India, International Liver Transplant Society and Founder member of Liver Transplant Society of India.

Comprised of Surgeons, Gastroenterologists, Intensivists, Anesthetists, Technicians, Counsellors and Specialised Nurses, Institute of Digestive & Liver Diseases at BLK Super Speciality Hospital offers robust and comprehensive treatment programmes for a wide range of digestive and liver diseases

Related Posts

To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

New ‘Bible’ of Nearly ‘Ideal’ Eating hit stands to become Instant Best Seller New Delhi: You are a veritable Hamlet when it comes to the question, to eat or not…

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Bharat Mandapam witnessed Spectacle of Crazy Innovations by Maker of Ssi Mantra, Best in class Surgical Robot New Delhi: It was a veritable display of innovative potential and prowess of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

Pak-made illegal cosmetics recovered from Itwari shop

Pak-made illegal cosmetics recovered from Itwari shop

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert